At the intersection of multiple oncogenic and cytoprotective pathways, NRF2 plays a direct or indirect role in each of the cancer hallmarks described thus far, including carcinogenesis, sustained proliferation, evasion of apoptosis, metabolic reprogramming, altered redox balance, formation of metastases, and resistance to therapy [12]. The gene discussed is NFE2L2; the disease is cancer.